Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Welcome to your trusted hub for comprehensive resources on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). Renowned international liver experts share invaluable insights and guidance to navigate and manage these conditions. Let's journey together towards better liver health.
Dr. Supriya Joshi, Hepatologist, and FLA Board member, shares insights into the world of fatty liver disease - NAFLD and NASH, now referred to as MASLD and MASH. With 14,000 followers and growing, Dr. Joshi openly shares her thoughts as an expert to help you navigate the world with a healthy liver and a healthy life.
Instagram Link:
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the obesity and metabolic syndrome epidemics, which this up-to-date book deals with comprehensively. The contents outline disease mechanisms, diagnostic tests, management, varying manifestations, and special populations. It covers the mechanistic pathways that contribute to NAFLD development, including the role of genetic variants and the gut microbiome. It elaborates on noninvasive diagnostic tests to screen for NAFLD, determine its severity, and monitor response to lifestyle intervention and pharmacologic treatment. This book helps clinicians diagnose and treat this common and potentially deadly disease.
Key Features:
There is new nomenclature for fatty liver disease. The change from NAFLD and NASH to MASLD and MASH has happened, and here is the background in the original published Hepatology journal paper.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.